Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome

NCT06776783 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

520

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Distress Syndrome
Pre-term Infants

Interventions

COMBINATION_PRODUCT: APC-0101 (SF-RI 1 surfactant for inhalation combined with a dedicated delivery system)
OTHER: Control

Sponsor

Aerogen Pharma Limited